BioCardia, Inc. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
BioCardia, Inc. (BCDA) reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $98.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2026-03-24
- BioCardia, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2025 was $98.00K, a 0.00% change from fiscal 2024.
- BioCardia, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2024 was $98.00K, a 37.97% decline from fiscal 2023.
- BioCardia, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $158.00K, a 4.64% increase from fiscal 2022.
- BioCardia, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $151.00K, a 4.43% decline from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $98.00K 10-K · filed 2026-03-24 |
| 2024-12-31 | $98.00K 10-K · filed 2026-03-24 |
| 2023-12-31 | $158.00K 10-K · filed 2025-03-26 |
| 2022-12-31 | $151.00K 10-K · filed 2024-03-27 |
| 2021-12-31 | $158.00K 10-K · filed 2023-03-29 |
| 2020-12-31 | $189.00K 10-K · filed 2022-03-29 |
| 2019-12-31 | $155.00K 10-K · filed 2021-03-30 |
| 2018-12-31 | $166.00K 10-K · filed 2020-04-09 |
| 2017-12-31 | $117.00K 10-K · filed 2019-04-02 |
| 2016-12-31 | $77.00K 10-K · filed 2018-03-16 |
| 2015-12-31 | $45.00K 10-K · filed 2017-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |